Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $618 | 6-8 weeks | |
50 mg | $945 | 6-8 weeks | |
100 mg | $1,689 | 6-8 weeks |
Description | FT-1518 ,exhibits antitumor activity, is a new generation selective, potent and oral bioavailable mTORC1 and mTORC2 inhibitor. |
In vitro | FT-1518 is a novel, selective, potent, and orally bioavailable inhibitor targeting both mTORC1 and mTORC2 pathways, demonstrated by its potent inhibition of key biomarkers (mTORC1 & 2 biomarkers [pAkt(S473) and pS6(S240/244) or p70 S6K]), without affecting the PI3K biomarker [pAkt(T308)]. This compound exhibits pronounced antitumor properties and has shown significant growth inhibitory effects across a wide array of hematologic and solid tumor cell lines, with the majority of its activities observed in the low nanomolar range. |
In vivo | FT-1518 demonstrates a dose-dependent increase in tumor growth inhibition (TGI) across a range of solid tumor xenografts, with more significant effects observed at higher doses. |
Molecular Weight | 394.47 |
Formula | C20H26N8O |
Cas No. | 1313026-58-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.